KKL-35

• Description:

  KKL-35 is a trans-translation tagging reaction inhibitor with an IC50 of 0.9 μM.

• UNSPSC:

  12352005

• Hazard Statement:

  H302

• Target:

  Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/KKL-35.html

• Purity:

  99.46

• Solubility:

  DMSO : 6.25 mg/mL (ultrasonic)

• Smiles:

  O=C (NC1=NN=C (C2=CC=C (F) C=C2) O1) C3=CC=C (Cl) C=C3

• Molecular Formula:

  C15H9ClFN3O2

• Molecular Weight:

  317.70

• Precautions:

  H302

• References & Citations:

  [1]Ramadoss NS, et al. Small molecule inhibitors of trans-translation have broad-spectrum antibiotic activity. Proc Natl Acad Sci U S A. 2013 Jun 18;110 (25) :10282-7.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  865285-29-6